Impaired SOX17 Expression Causes Endothelial Dysfunction and Pulmonary Arterial Hypertension by Insufficient Suppression of RUNX1
Bedia Akosman, Moon Jung Choi, Yamini Sharma, Mandy Pereira, Young Eun Lee, Eui Young So, Allyson Sherman‐Roe, Navneet Singh, Anthony M. Reginato, Corey E. Ventetuolo, Martin Wilkins, Lan Zhao, Christopher J. Rhodes, James R. Klinger, Olin D. Liang
This study shows that impaired SOX17 expression increases pulmonary arterial hypertension risk by failing to suppress RUNX1, leading to endothelial dysfunction, and that RUNX1 inhibition can mitigate this condition.
bioRxiv · May 15, 2026 · PreprintCell Biology